Sam-A Pharm Balance Sheet Health
Financial Health criteria checks 5/6
Sam-A Pharm has a total shareholder equity of ₩200.5B and total debt of ₩4.2B, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₩231.3B and ₩30.8B respectively. Sam-A Pharm's EBIT is ₩23.5B making its interest coverage ratio -5.3. It has cash and short-term investments of ₩79.1B.
Key information
2.1%
Debt to equity ratio
₩4.17b
Debt
| Interest coverage ratio | -5.3x |
| Cash | ₩79.10b |
| Equity | ₩200.47b |
| Total liabilities | ₩30.84b |
| Total assets | ₩231.31b |
Recent financial health updates
Recent updates
Key Things To Consider Before Buying Sam-A Pharm. Co., Ltd (KOSDAQ:009300) For Its Dividend
Apr 08
Is Sam-A Pharm (KOSDAQ:009300) A Risky Investment?
Mar 04How Much Did Sam-A Pharm's(KOSDAQ:009300) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28
Four Days Left To Buy Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Before The Ex-Dividend Date
Dec 24Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Is Yielding 1.6% - But Is It A Buy?
Dec 07Financial Position Analysis
Short Term Liabilities: A009300's short term assets (₩118.0B) exceed its short term liabilities (₩21.1B).
Long Term Liabilities: A009300's short term assets (₩118.0B) exceed its long term liabilities (₩9.7B).
Debt to Equity History and Analysis
Debt Level: A009300 has more cash than its total debt.
Reducing Debt: A009300's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Debt Coverage: A009300's debt is well covered by operating cash flow (498.3%).
Interest Coverage: A009300 earns more interest than it pays, so coverage of interest payments is not a concern.